Venbio Partners LLC’s Harmony Biosciences Hldgs In Position
Does Venbio Partners LLC own Harmony Biosciences Hldgs In (HRMY)? Yes — 489.2K shares worth $14M (+4.88% of its 13F portfolio) as of Q1 2026.
Position Value
$14M
Q1 2026
Shares
489.2K
% of Portfolio
+4.88%
Quarters Held
23
currently held
Position History HRMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 489.2K | $14M | +4.88% |
| Q4 2025 | 489.2K | $18M | +8.46% |
| Q3 2025 | 489.2K | $13M | +7.64% |
| Q2 2025 | 489.2K | $15M | +13.47% |
| Q1 2025 | 489.2K | $16M | +13.14% |
| Q4 2024 | 539.2K | $19M | +10.87% |
| Q3 2024 | 614.6K | $25M | +12.65% |
| Q2 2024 | 1.04M | $31M | +13.49% |
| Q1 2024 | 1.04M | $35M | +12.33% |
| Q4 2023 | 1.04M | $33M | +5.01% |
| Q3 2023 | 1.04M | $34M | +9.62% |
| Q2 2023 | 1.04M | $36M | +13.19% |
| Q1 2023 | 1.04M | $34M | +18.74% |
| Q4 2022 | 1.04M | $57M | +17.69% |
| Q3 2022 | 1.13M | $50M | +11.53% |
| Q2 2022 | 1.45M | $71M | +20.12% |
| Q1 2022 | 1.54M | $75M | +16.66% |
| Q4 2021 | 2.74M | $117M | +21.05% |
| Q3 2021 | 3.06M | $117M | +11.70% |
| Q2 2021 | 3.50M | $99M | +11.68% |
| Q1 2021 | 3.50M | $116M | +11.00% |
| Q4 2020 | 3.50M | $127M | +11.18% |
| Q3 2020 | 3.50M | $119M | +18.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venbio Partners LLC’s full portfolio or all institutional holders of HRMY.